In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

Published Date: 09 Feb 2024

95% of participants responded overall in the small trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A prostate cancer risk prediction algorithm could help target men at highest risk

2.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

3.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

4.

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

5.

Should the UK introduce targeted prostate cancer screening? The case for and against


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot